David J. Moss - 12 Sep 2024 Form 4 Insider Report for Inmune Bio, Inc. (INMB)

Role
Chief Financial Officer, 10%+ Owner
Signature
/s/ David Moss
Issuer symbol
INMB
Transactions as of
12 Sep 2024
Transactions value $
$49,985
Form type
4
Filing time
16 Sep 2024, 20:47:21
Previous filing
16 May 2024
Next filing
30 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INMB Common Stock Purchase $49K +7.69K +0.61% $6.38 1.28M 12 Sep 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INMB Common Stock Warrants (right to buy) Purchase $961 +7.69K $0.13* 7.69K 12 Sep 2024 Common Stock 7.69K $6.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The common shares and warrants reported on this Form 4 were purchased in a registered direct offering at a price of $6.50, for an aggregate purchase price of $13,000,000 pursuant to a securities purchase agreement dated September 12, 2024. The Warrants are exercisable on or after March 16, 2025 and will terminate on March 16, 2030 unless such termination is accelerated pursuant to the terms of the Warrants (the "Termination Date"), provided, however, in the event that the Warrant is held by Insiders and the Termination Date is during a period that such Insiders are subject to a blackout with respect to trading in the Company's common stock, such Insiders will have an additional 60 days from the termination of the blackout to exercise the Warrant. The exercise price the Warrants is $6.40 per share subject to adjustment as provided in the Warrant.